Erratum: Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing.

The Competing financial interests statement in the HTML version of this Article should read:

“Masakazu Hashimoto, Tokushima University, and BEX Co. Ltd. applied for a patent describing this method (application number: 2015-031006). M.H. and T.T. are listed as inventors of the patent, and will receive part of the reward that it may generate.”